Invitrogen Sues Harvard Over Cloning Patent

Law360, New York (May 17, 2007, 12:00 AM EDT) -- A California life sciences company has hit the president and fellows of Harvard College with an intellectual property lawsuit, accusing the university’s top guardians of wrongly laying claim to a molecular cloning patent.

On Tuesday, Invitrogen Corp. filed suit in the U.S. District Court for the District of Massachusetts, hoping to reverse a decision handed down by the board of patent appeals and interferences of the U.S. Patent and Trademark Office.

“This is a civil action to remedy the decisions and judgment of the Board adverse...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.